Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The complexity of microRNAs in human cancer

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          MicroRNAs (miRNAs) are small non-coding RNA molecules that have key regulatory roles in cancer, acting as both oncogenes and tumor suppressors. Due to the potential roles of miRNAs in improving cancer prognostic, predictive, diagnostic and therapeutic approaches, they have become an area of intense research focus in recent years. MiRNAs harbor attractive features allowing for translation to the clinical world, such as relatively simple extraction methods, resistance to molecular degradation, and ability to be quantified. Numerous prognostic, predictive and diagnostic miRNA signatures have been developed. To date however, miRNA analysis has not been adopted for routine clinical use. The objectives of this article are to provide an overview of miRNA research and review a selection of miRNA studies in breast cancer, cervical cancer, sarcoma, and nasopharyngeal carcinoma to highlight advances and challenges in miRNA cancer research.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          MicroRNA profiling: approaches and considerations.

          MicroRNAs (miRNAs) are small RNAs that post-transcriptionally regulate the expression of thousands of genes in a broad range of organisms in both normal physiological contexts and in disease contexts. miRNA expression profiling is gaining popularity because miRNAs, as key regulators in gene expression networks, can influence many biological processes and also show promise as biomarkers for disease. Technological advances have spawned a multitude of platforms for miRNA profiling, and an understanding of the strengths and pitfalls of different approaches can aid in their effective use. Here, we review the major considerations for carrying out and interpreting results of miRNA-profiling studies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The microcosmos of cancer.

            The discovery of microRNAs (miRNAs) almost two decades ago established a new paradigm of gene regulation. During the past ten years these tiny non-coding RNAs have been linked to virtually all known physiological and pathological processes, including cancer. In the same way as certain key protein-coding genes, miRNAs can be deregulated in cancer, in which they can function as a group to mark differentiation states or individually as bona fide oncogenes or tumour suppressors. Importantly, miRNA biology can be harnessed experimentally to investigate cancer phenotypes or used therapeutically as a target for drugs or as the drug itself.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              MicroRNAs in cancer: small molecules with a huge impact.

              Every cellular process is likely to be regulated by microRNAs, and an aberrant microRNA expression signature is a hallmark of several diseases, including cancer. MicroRNA expression profiling has indeed provided evidence of the association of these tiny molecules with tumor development and progression. An increasing number of studies have then demonstrated that microRNAs can function as potential oncogenes or oncosuppressor genes, depending on the cellular context and on the target genes they regulate. Here we review our current knowledge about the involvement of microRNAs in cancer and their potential as diagnostic, prognostic, and therapeutic tools.
                Bookmark

                Author and article information

                Journal
                J Radiat Res
                J. Radiat. Res
                jrr
                jrr
                Journal of Radiation Research
                Oxford University Press
                0449-3060
                1349-9157
                August 2016
                16 August 2016
                16 August 2016
                : 57
                : Suppl 1
                : i106-i111
                Affiliations
                [1 ]Ontario Cancer Institute, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada
                [2 ]Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
                [3 ]Department of Radiation Oncology, Faculty of Medicine, University of Toronto, 149 College Street, Suite 504, Toronto, ON, M5T 1P5, Canada
                [4 ]Department of Medical Biophysics, University of Toronto, 101 College Street, Room 15-701, Toronto, ON, M5G 1L7, Canada
                Author notes
                [* ]Corresponding author: Department of Radiation Oncology, Princess Margaret Cancer Center/Ontario Cancer Institute, 610 University Ave, Toronto, Ontario, M5G 2M9, Canada. Tel: +1-416-946-2123; Fax: +1-416-946-2038; E-mail: Fei-Fei.Liu@ 123456rmp.uhn.on.ca
                Article
                rrw009
                10.1093/jrr/rrw009
                4990105
                26983984
                25c6da6b-ed4d-4825-93a4-84eb56e908a6
                © The Author 2016. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 24 September 2015
                : 4 January 2016
                : 15 January 2016
                Page count
                Pages: 6
                Funding
                Funded by: Canadian Institutes of Health Research, http://dx.doi.org/10.13039/501100000024;
                Funded by: Ontario Institute for Cancer Research, http://dx.doi.org/10.13039/501100004203;
                Funded by: Canadian Breast Cancer Foundation, http://dx.doi.org/10.13039/501100000147;
                Funded by: Canadian Breast Cancer Research Alliance, http://dx.doi.org/10.13039/501100000150;
                Funded by: Canadian Institutes of Health Research, http://dx.doi.org/10.13039/501100000024;
                Categories
                Supplement – ICRR highlights

                Oncology & Radiotherapy
                microrna,breast cancer,cervical cancer,sarcoma,nasopharyngeal carcinoma
                Oncology & Radiotherapy
                microrna, breast cancer, cervical cancer, sarcoma, nasopharyngeal carcinoma

                Comments

                Comment on this article